Anti-imperfection Treatment La Roche Posay Effaclar Duo+M 40 ml
search
  • Anti-imperfection Treatment La Roche Posay Effaclar Duo+M 40 ml
  • Anti-imperfection Treatment La Roche Posay Effaclar Duo+M 40 ml

Anti-imperfection Treatment La Roche Posay Effaclar Duo+M 40 ml

17,26 $
usdttrc20 logo
17.26191586 USDTTRC20
Anti-imperfection Treatment La Roche Posay Effaclar Duo+M 40 ml is a quality product designed for discerning individuals who look after their appearance and are looking for the best cosmetics to...
Quantité

We're finding the best carriers for you. Just a moment!
  Delivery policy

(edit with the Customer Reassurance module)

  Return policy

Retour sous 14 jours gratuit

Anti-imperfection Treatment La Roche Posay Effaclar Duo+M 40 ml is a quality product designed for discerning individuals who look after their appearance and are looking for the best cosmetics to enhance their beauty. If you are one of them, the 100% original La Roche Posay products are made for you.



  • Type: Cosmetics
  • Characteristics: Day/Night
  • Gender: Unisex
  • Texture: Cream
  • Recommended use:
    • Combination Skin
    • Oily skin
    • Skin with a tendency to acne
  • Ingredients:
    • Piroctone olamine
    • Poloxamer 338
    • Polysorbate 80
    • Potassium cetyl phosphate
    • Salicylic acid
    • Silica
    • Sodium hydroxide
    • Sorbitan oleate
    • Vitreoscilla ferment
    • Water (Aqua)
    • Xanthan gum
    • Zinc pca
    • Acrylamide/ sodium acryloyldimethyltaurate copolymer
    • Aluminum starch octenylsuccinate
    • Ammonium polyacryloyldimethyl taurate
    • Capryloyl salicylic acid
    • Caprylyl glycol
    • Dimethicone
    • Disodium edta
    • Glyceryl stearate se
    • Isocetyl stearate
    • Isohexadecane
    • Isopropyl lauroyl sarcosinate
    • Mannose
    • Methyl methacrylate crosspolymer
    • Myristyl myristate
    • Niacinamide
    • Glycerin
    • Octadecanediol
  • Capacity: 40 ml
S05117458
175 Produits

Références spécifiques

EAN-13
3337875863377
Commentaires (0)
Aucun avis n'a été publié pour le moment.